" class="no-js "lang="en-US"> Matthew Cox - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Matt Cox

Matthew Cox

About Matthew Cox

Better data = Better care. We help clinicians make better clinical decisions with over 22m patients world wide so far and growing. Our Open platform, vision and culture will help transform the health system for the better, together

Related Story

News

 Better Contracted to Deliver Clinical Data Repository for Wales | Pharmtech Focus

Better Contracted to Deliver Clinical Data Repository for Wales

July 7 2021

Digital Health and Care Wales has awarded a two-year contract to Better for a clinical […]

News

 ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS | Pharmtech Focus

ReStart and Better Announce a Partnership to Improve Data Interoperability Within the NHS

July 1 2021

ReStart and Better have signed a partnership agreement to improve interoperability between NHS organisations, regardless of […]